The objectives of the educational core will be to provide 1. Education in nanotechnolgy and cancer for students, faculty and staff of participating institutions. 2. Enhanced communication among students, faculty and staff within and between member institutions through group educational opportunities and net based portals 3. Education and awareness in nanotechnology applications in cancer for community health care providers in oncology Our overall aim is to provide education and facilitate communication in the community for applications of nanotechnology to oncology. To achieve these objectives the specific aims of the center will include AIM 1: Identification, collection, organization and communication of courses at member institutions in nanotechnology and oncology AIM 2: Creation of seminar series to focus on nanotechnology and oncology and their audio/visual archive through CCNE website AIM 3: Development, implementation, webcast and archive of forums and workshops to facilitate discussions among members of CCNE.
AIM 4 : Outreach to community health care providers in oncology through on-site seminars, webcasts, and internet portal AIM 5: Institute workshops at national meetings with presentations by all the CCNE's Public relevance. The educational component of this Center for Cancer and Nanotechnology Excellece seeks to promote the education in the new field of nanotechnology for cancer scientists and in the field of cancer for the engineers, chemists and physicists who conduct research in nanotechnology. We also seek to provide venues for these different scientists from different organizations in different parts of California to chat and discuss ideas. Simultaneously, we shall bring our knowledge of cancer and nanotechnology to health care providers specializing in cancer treatment so that they can understand the tools of treatment and diagnosis which will be available to them in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA119335-05
Application #
7932987
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$394,246
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Schutt, Carolyn; Ibsen, Stuart; Zahavy, Eran et al. (2017) Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin. Pharm Res 34:2025-2035
Heineck, D P; Lewis, J M; Heller, M J (2017) Electrokinetic device design and constraints for use in high conductance solutions. Electrophoresis 38:1475-1482
Manouchehri, Sareh; Ibsen, Stuart; Wright, Jennifer et al. (2016) Dielectrophoretic recovery of DNA from plasma for the identification of chronic lymphocytic leukemia point mutations. Int J Hematol Oncol 5:27-35
Sandoval, Sergio; Mendez, Natalie; Alfaro, Jesus G et al. (2015) Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform. J Biomed Opt 20:88003
Goodwin, Andrew P; Nakatsuka, Matthew A; Mattrey, Robert F (2015) Stimulus-responsive ultrasound contrast agents for clinical imaging: motivations, demonstrations, and future directions. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:111-23
Campbell, Diahnn F; Saenz, Rebecca; Bharati, Ila S et al. (2015) Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles. Breast Cancer Res 17:48
Ortac, Inanc; Simberg, Dmitri; Yeh, Ya-san et al. (2014) Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes. Nano Lett 14:3023-32
Sonnenberg, Avery; Marciniak, Jennifer Y; Rassenti, Laura et al. (2014) Rapid electrokinetic isolation of cancer-related circulating cell-free DNA directly from blood. Clin Chem 60:500-9
Saenz, R; Messmer, B; Futalan, D et al. (2014) Activity of the HMGB1-derived immunostimulatory peptide Hp91 resides in the helical C-terminal portion and is enhanced by dimerization. Mol Immunol 57:191-9
Sonnenberg, Avery; Marciniak, Jennifer Y; Skowronski, Elaine A et al. (2014) Dielectrophoretic isolation and detection of cancer-related circulating cell-free DNA biomarkers from blood and plasma. Electrophoresis 35:1828-36

Showing the most recent 10 out of 146 publications